summary: In this study of over 1,200 people with MS, the authors tested the trustworthiness of the BREMS, that is an estimate score of the risk of reaching secondary progression within the first year of disease. They conclude that BREMS is a useful tool to identify the high-risk patients.

authors: Bergamaschi R, Quaglini S, Trojano M, Amato MP, Tavazzi E, Paolicelli D, Zipoli V, Romani A, Fuiani A, Portaccio E, Berzuini C, Montomoli C, Bastianello S, Cosi V.

source: J Neurol Neurosurg Psychiatry. 2007 Jan 12; [Epub ahead of print]

weblink: click here

category: Epidemiology

related research news: click here

glossary: